Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fiegl

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Journal of Palliative Medicine|June 30, 2011
Quality of life trajectory in patients with advanced cancer during the last year of lifeJohannes M Giesinger, Lisa M Wintner, Anne S Oberguggenberger, et al.
The Journal of Clinical Investigation|December 30, 2009
Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis inductionIsmael Samudio, Romain Harmancey, Michael Fiegl, et al.
Annals of Hematology|November 13, 2014
Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trialInes Wasle, Gabriele Gamerith, Florian Kocher, et al.
Wiener Klinische Wochenschrift|April 12, 2011
Routine use of bendamustine and rituximab combination therapy in consecutive patients with lymphoproliferative diseases: a survey from Tyrolean hospitalsChristian Waldthaler, Reinhard Stauder, Michael Schnallinger, et al.
Annals of Hematology|April 13, 2013
"Idiopathic Bence-Jones proteinuria": a new characterization of an old entityMichael Mian, Irene Franz, Ines Wasle, et al.
Anticancer Research|April 30, 2014
A success story: how a single targeted-therapy molecule impacted on treatment and outcome of diffuse large B-cell lymphomaMichael Mian, Florian Augustin, Florian Kocher, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 1, 2015
Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in AustriaGregor Aschauer, Richard Greil, Werner Linkesch, et al.
Journal of the National Cancer Institute|August 22, 2002
Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapyJohan Vansteenkiste, Robert Pirker, Bartomeu Massuti, et al.
Cancers|October 27, 2022
Molecular Characteristics of Radon Associated Lung Cancer Highlights MET AlterationsGabriele Gamerith, Marcel Kloppenburg, Finn Mildner, et al.
Scientific Reports|December 18, 2015
IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemiaAlexander Kuett, Christina Rieger, Deborah Perathoner, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Journal of Palliative Medicine|June 30, 2011
Quality of life trajectory in patients with advanced cancer during the last year of lifeJohannes M Giesinger, Lisa M Wintner, Anne S Oberguggenberger, et al.
The Journal of Clinical Investigation|December 30, 2009
Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis inductionIsmael Samudio, Romain Harmancey, Michael Fiegl, et al.
Annals of Hematology|November 13, 2014
Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trialInes Wasle, Gabriele Gamerith, Florian Kocher, et al.
Wiener Klinische Wochenschrift|April 12, 2011
Routine use of bendamustine and rituximab combination therapy in consecutive patients with lymphoproliferative diseases: a survey from Tyrolean hospitalsChristian Waldthaler, Reinhard Stauder, Michael Schnallinger, et al.
Annals of Hematology|April 13, 2013
"Idiopathic Bence-Jones proteinuria": a new characterization of an old entityMichael Mian, Irene Franz, Ines Wasle, et al.
Anticancer Research|April 30, 2014
A success story: how a single targeted-therapy molecule impacted on treatment and outcome of diffuse large B-cell lymphomaMichael Mian, Florian Augustin, Florian Kocher, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 1, 2015
Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in AustriaGregor Aschauer, Richard Greil, Werner Linkesch, et al.
Journal of the National Cancer Institute|August 22, 2002
Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapyJohan Vansteenkiste, Robert Pirker, Bartomeu Massuti, et al.
Cancers|October 27, 2022
Molecular Characteristics of Radon Associated Lung Cancer Highlights MET AlterationsGabriele Gamerith, Marcel Kloppenburg, Finn Mildner, et al.
Scientific Reports|December 18, 2015
IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemiaAlexander Kuett, Christina Rieger, Deborah Perathoner, et al.
Pageof 12